Navigation Links
Boston Scientific Announces Results For Second Quarter Ended June 30, 2013
Date:7/25/2013

oston Scientific.  "As we continue to expand our portfolio, our team is inspired to deliver meaningful innovation to more patients globally."Worldwide sales for the second quarter: Three Months EndedJune 30,% Changein millions20132012As Reported BasisLess: Impact of Foreign CurrencyConstant Currency BasisInterventional Cardiology

$

520$

549(5)%

$

(15)(2)%

(3)%Peripheral Interventions

1991962%

(6)(3)%

5%Cardiovascular719745(4)%(21)(3)%(1)%Cardiac Rhythm Management

475488(3)%

(4)(1)%

(2)%Electrophysiology

3637(3)%

(1)(1)%

(2)%Rhythm Management511525(3)%(5)(1)%(2)%Endoscopy

3253115%

(11)(3)%

8%Urology/Women's Health

124126(1)%

(3)(2)%

1%Neuromodulation

1119121%

10%

21%MedSurg5605286%(13)(3)%9%Subtotal Core Businesses1,7901,7980%(39)(2)%2%Divested Businesses

1930(36)%

12%

(38)%Worldwide Net Sales$1,809$1,828(1)%$(38)(2)%1%Growth rates are based on actual, non-rounded amounts and may not recalculate precisely.

 Sales growth rates that exclude the impact of changes in foreign currency exchange rates are not prepared in accordance with U.S. GAAP.  An explanation of the company's use of these non-GAAP financial measures is included in the exhibits attached to this news release.

  

On a consolidated GAAP basis, net income for the second quarter of 2013 was $130 million, or earnings of $0.10 per share.  These results included an intangible asset impairment charge, acquisition- and divestiture-related net credits, restructuring-related charges, and amortization expense, of $117 million (after-tax) or $0.08 per share.  Adjusted net income for the second quarter of 2013, excluding these net charges, was $247 million, or $0.18 per share.

On a consolidated GA
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. American Laboratory Trading Continues Steady Growth with Expansion in Boston
2. Affordable Scrum Training in Boston,MA by Conscires Agile Practices
3. Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston
4. The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA
5. Verified Clinical Trials (VCT) Will Co-Present With SAFE-BioPharma At Bio-IT World April 10th In Boston, MA Exploring Identity Management In eClinical Trials
6. Boston Heart Diagnostics Awarded $450,000 in Tax Incentives from the Massachusetts Life Sciences Center
7. Local Leaders Convene in Boston to Share Industry Best Practices in Second “Business of Big Data” Summit
8. R&D, Innovation Key to Success - Research Report on Varian Medical Systems, Inc., Boston Scientific Corporation, Stryker Corporation, St. Jude Medical, Inc., and Thermo Fischer Scientific Inc.
9. Boston College researchers unique nanostructure produces novel plasmonic halos
10. Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2012 Financial Results on January 29th
11. Shire and Boston Childrens Hospital Enter Into Broad Research Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... (PRWEB) April 01, 2015 Biosearch ... Biosearch to make, use, market and sell Co-Diagnostics’ ... licenses CoPrimers™ technology to Biosearch for its own ... greatly reduces the occurrence of primer-dimers, without the ... increased sensitivity and lower test prices. , ...
(Date:4/1/2015)... 1, 2015  VLP Therapeutics, LLC. ("VLP"), a ... research and development of therapeutic and preventative vaccines and ... proprietary vaccine technology, today announced that it has entered into ... at Nagasaki University in ... research and development of dengue vaccine candidates. ...
(Date:4/1/2015)...  EMD Serono, the U.S. biopharmaceuticals subsidiary of Merck ... the appointment of Frederick E. Munschauer to ... this capacity, he will lead the medical affairs activities ... for Rebif ® (interferon beta-1a) as well as ... Dr. Munschauer joins EMD Serono from Biogen, bringing more ...
(Date:4/1/2015)... , April 1, 2014 /CNW/ - Canada,s ... Review Board,s (PMPRB) newly released report on Cost Drivers of ... notes that, according to the report, the rates of change ... reaching a low of -0.8 percent in 2012/13 for a ... any study that examines the costs of medicines without considering ...
Breaking Biology Technology:Biosearch and Co-Diagnostics Sign Cooperative Primers Agreement 2Biosearch and Co-Diagnostics Sign Cooperative Primers Agreement 3VLP Therapeutics Enters Collaboration with Institute of Tropical Medicine, Nagasaki University 2VLP Therapeutics Enters Collaboration with Institute of Tropical Medicine, Nagasaki University 3EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 2EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 3EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 4EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 5Rx&D responds to PMPRB report: overall impact of medicines must always be considered 2
... AMSTERDAM, November 11 Amsterdam Molecular,Therapeutics (Euronext: AMT), ... today that it has successfully treated Duchenne muscular dystrophy,(DMD) ... The proof of,concept studies were performed in collaboration with ... Sapienza, Italy) and demonstrated,effectiveness in the heart as well ...
... THE WOODLANDS, Texas, Nov. 10 Today, US ... , executive vice president and general counsel, will be ... http://www.newscom.com/cgi-bin/prnh/20091110/DA08765 ) , Watts has had a long ... worked with US Oncology providing legal services and consultation as ...
... , ST. LOUIS, Nov. 10 At the Board of ... dividend of $.145 per share, an 11.5% increase over the ... 2009 to shareholders of record on December 1, 2009. , ... Life Science and High Technology company. Our chemical and biochemical ...
Cached Biology Technology:AMT Successful in Preclinical Treatment of DMD 2AMT Successful in Preclinical Treatment of DMD 3US Oncology Announces Retirement of General Counsel Phil Watts 2
(Date:3/23/2015)... Mass , March 23, 2015 SoundView Technology ... of NXT-ID,s (NASDAQ: NXTD ) Wocket smart wallet. SoundView was ... user feedback on their experience with the Wocket in multiple ... at CVS, Whole Foods and other retailers, making both debit ... Kris Tuttle also says, "If the company meets their ...
(Date:3/20/2015)... DUBLIN , Mar. 20, 2015 Research ... announced the addition of the "India Sensors ... their offering. The sensor market is ... through 2020 Consumer electronics, automotive, industrial ... for sensors in the country. In addition, adoption ...
(Date:3/19/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... growing mobile commerce market, announces its biometric payment technology, the ... aired this week on Washington DC,s ... a segment "The Next Great Thing", host Laura Evans ... pay, and ,a really big breakthrough in mobile payment.,  ...
Breaking Biology News(10 mins):Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
... research published today in BioMed Central,s open access journal ... Rafflesia cantleyi , with its 50cm diameter flowers, has ,stolen, ... these genes shows that their functions range from respiration to ... parasites own gene activity. Vertical gene transfer is that ...
... of North America, are in trouble mostly because of inadequate ... impact, according to work published June 6 in the open ... led by Katherine Ayres, who completed the work while at ... fecal thyroid and glucocorticoid, to distinguish between two different theories ...
... Communities of microbial organisms -- species such as ... Gulf of Mexico changed significantly following the Deepwater Horizon ... of New Hampshire,s Hubbard Center for Genome Studies (HCGS) ... from five Gulf Coast sites prior to and several ...
Cached Biology News:Parasitic plants 'steal' genes from their hosts 2Microbial communities shifted dramatically after Deepwater Horizon spill 2
EZ-DeWax is a one-step solution that simultanously removes paraffin from and rehydrates formalin-fixed, paraffin embedded tissue...
Artisan™ Wash Solution (x 50) Additional Information: EU regulatory status: CE US regulatory status: IVD ...
... an inexpensive personal or mini thermal cycler, and ... with a small footprint, it can be easily ... desk. , The Gene Cycler thermal cycler meets ... access to a large laboratory thermal cycler, or ...
... Detection System is intended for use with ... reagents, which contain rat and goat IgG ... light microscopy in paraffin-embedded tissues. The IHC ... be used with other rat or goat ...
Biology Products: